Immunosuppression

Deliberately induced

Administration of immunosuppressive medications or immunosuppressants is the main method for deliberately inducing immunosuppression; in optimal circumstances, immunosuppressive drugs primarily target hyperactive components of the immune system. People in remission from cancer who require immunosuppression are not more likely to experience a recurrence. Throughout its history, radiation therapy has been used to decrease the strength of the immune system. Dr. Joseph Murray of Brigham and Women's Hospital was given the Nobel Prize in Physiology or Medicine in 1990 for work on immunosuppression.

Immunosuppressive drugs have the potential to cause immunodeficiency, which can increase susceptibility to opportunistic infection and decrease cancer immunosurveillance. Immunosuppressants may be prescribed when a normal immune response is undesirable, such as in autoimmune diseases.

Steroids were the first class of immunosuppressant drugs identified, though side-effects of early compounds limited their use. The more specific azathioprine was identified in 1960, but it was the discovery of ciclosporin in 1980 (together with azathioprine) that allowed significant expansion of transplantation to less well-matched donor-recipient pairs as well as broad application to lung transplantation, pancreas transplantation, and heart transplantation.

Non-deliberate immunosuppression

Non-deliberate immunosuppression can occur in, for example, ataxia–telangiectasia, complement deficiencies, many types of cancer, and certain chronic infections such as human immunodeficiency virus (HIV). The unwanted effect in non-deliberate immunosuppression is immunodeficiency that results in increased susceptibility to pathogens, such as bacteria and viruses.

Immunodeficiency is also a potential adverse effect of many immunosuppressant drugs, in this sense, the scope of the term immunosuppression in general includes both beneficial and potential adverse effects of decreasing the function of the immune system.

B cell deficiency and T cell deficiency are immune impairment that individuals are born with or are acquired, which in turn can lead to immunodeficiency problems. Nezelof syndrome is an example of an immunodeficiency of T-cells.

References

References

1. "Immunodeficiency disorders: MedlinePlus Medical Encyclopedia".
2. (2011-02-02). "NCI Dictionary of Cancer Terms".
3. (2017-01-06). "Immunosuppression: Overview, History, Drugs".
4. (2011-02-02). "NCI Dictionary of Cancer Terms".
5. Wiseman, Alexander C.. (2016-02-05). "Immunosuppressive Medications". Clinical Journal of the American Society of Nephrology.
6. (July 2016). "Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis". Gastroenterology.
7. (2016-03-15). "Mosby's Guide to Nursing Diagnosis - E-Book". Elsevier Health Sciences.
8. "Joseph E. Murray - Facts".
9. (2015-04-29). "Immunosuppression".
10. Chandrashekara, S.. (2012). "The treatment strategies of autoimmune disease may need a different approach from conventional protocol: A review". Indian Journal of Pharmacology.
11. "Transplant rejection: MedlinePlus Medical Encyclopedia".
12. (2017-03-09). "Immunology of Transplant Rejection: Overview, History, Types of Grafts".
13. (2001). "Responses to alloantigens and transplant rejection". Garland Science.
14. (2011). "Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases". Current Neuropharmacology.
15. "Immunodeficiency (Primary and Secondary). Information.".
16. (2003). "NORD Guide to Rare Disorders". Lippincott Williams & Wilkins.